Trial Profile
A Phase I/Ⅱ Open, Single Center, One-armed Trail, Neo - MASCT Treatment for Advanced NSCLC of the Safety and Efficacy.
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs MASCT I (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 05 Jul 2017 New trial record